Innoviva (INVA) News Today $17.53 +0.20 (+1.15%) As of 11:50 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Intech Investment Management LLC Has $609,000 Holdings in Innoviva, Inc. (NASDAQ:INVA)Intech Investment Management LLC raised its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 79.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 35,128 shares of the biotecMarch 25 at 4:03 AM | marketbeat.comCharles Schwab Investment Management Inc. Sells 104,634 Shares of Innoviva, Inc. (NASDAQ:INVA)Charles Schwab Investment Management Inc. lessened its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 14.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 627,662 shares of the biotechnology company's stock after selling 104,634 shares dMarch 23 at 3:02 AM | marketbeat.comBoston Partners Purchases 149,060 Shares of Innoviva, Inc. (NASDAQ:INVA)Boston Partners lifted its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 43.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 490,404 shares of the biotechnology company's stockMarch 22 at 4:45 AM | marketbeat.comBillionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 StocksMarch 17, 2025 | msn.comBillionaire Healthcare Investor Alex Denner's Hedge Fund Has 75% of Its Assets in These 3 StocksMarch 17, 2025 | 247wallst.comInnoviva, Inc. (NASDAQ:INVA) Shares Purchased by Victory Capital Management Inc.Victory Capital Management Inc. increased its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 26.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 177,383 shares of theMarch 17, 2025 | marketbeat.comWEX, Lamb Weston, and More Stocks See Action From Activist InvestorsMarch 15, 2025 | msn.comInnoviva (NASDAQ:INVA) Downgraded by StockNews.com to HoldStockNews.com lowered shares of Innoviva from a "buy" rating to a "hold" rating in a research report on Saturday.March 15, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Sees Strong Trading Volume - What's Next?Innoviva (NASDAQ:INVA) Sees Strong Trading Volume - Here's WhyMarch 14, 2025 | marketbeat.comArmata Pharmaceuticals Announces $10 Million Secured Credit Agreement with InnovivaMarch 12, 2025 | prnewswire.comAlphaQuest LLC Buys New Shares in Innoviva, Inc. (NASDAQ:INVA)AlphaQuest LLC bought a new stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 48,878 shares of the biotechnology company's stock, valued at approxiMarch 11, 2025 | marketbeat.comInceptionr LLC Acquires Shares of 16,542 Innoviva, Inc. (NASDAQ:INVA)Inceptionr LLC bought a new position in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 16,542 shares of the biotechnology company's stock, valued atMarch 10, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Raised to "Buy" at StockNews.comStockNews.com upgraded Innoviva from a "hold" rating to a "buy" rating in a report on Friday.March 8, 2025 | marketbeat.comScotiabank Initiates Coverage of Innoviva (INVA) with Sector Outperform RecommendationMarch 8, 2025 | msn.comInnoviva (NASDAQ:INVA) Coverage Initiated by Analysts at ScotiabankScotiabank began coverage on Innoviva in a research note on Friday. They set a "sector outperform" rating and a $55.00 price target on the stock.March 8, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $2,665,215.25 in StockInnoviva, Inc. (NASDAQ:INVA - Get Free Report) major shareholder Alexander J. Denner sold 151,175 shares of the business's stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $17.63, for a total transaction of $2,665,215.25. Following the sale, the insider now directly owns 7,125,825 shares in the company, valued at $125,628,294.75. The trade was a 2.08 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.March 8, 2025 | marketbeat.comAlexander J. Denner Sells 1,196,746 Shares of Innoviva, Inc. (NASDAQ:INVA) StockInnoviva, Inc. (NASDAQ:INVA - Get Free Report) major shareholder Alexander J. Denner sold 1,196,746 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $17.52, for a total value of $20,966,989.92. Following the sale, the insider now directly owns 5,658,705 shares of the company's stock, valued at approximately $99,140,511.60. This represents a 17.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.March 8, 2025 | marketbeat.comInnoviva initiated with an Outperform at ScotiabankMarch 7, 2025 | markets.businessinsider.comInnoviva to Participate in the Barclays 27th Annual Global Healthcare ConferenceMarch 6, 2025 | finance.yahoo.comInnoviva (NASDAQ:INVA) Posts Quarterly Earnings ResultsInnoviva (NASDAQ:INVA - Get Free Report) announced its quarterly earnings results on Wednesday. The biotechnology company reported $0.57 earnings per share (EPS) for the quarter. Innoviva had a return on equity of 20.84% and a net margin of 18.31%.February 27, 2025 | marketbeat.comInnoviva (INVA) to Release Earnings on ThursdayInnoviva (NASDAQ:INVA) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports.February 27, 2025 | marketbeat.comTheravance Biopharma Inc (TBPH) Q4 2024 Earnings Call Highlights: Record Sales and Strategic ...February 27, 2025 | gurufocus.comQ4 2024 Theravance Biopharma Inc Earnings Call TranscriptFebruary 27, 2025 | gurufocus.comTheravance Biopharma: Balancing Growth Potential and Uncertainty with a Hold RatingFebruary 26, 2025 | tipranks.comInnoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company ProgressFebruary 26, 2025 | businesswire.comDenali Advisors LLC Lowers Holdings in Innoviva, Inc. (NASDAQ:INVA)Denali Advisors LLC lowered its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 6.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 354,324 shares of the biotechnology company's stock after selling 26,078 shares during the period. DenaliFebruary 26, 2025 | marketbeat.comInnoviva: Underappreciated Strength In Hospital TherapeuticsFebruary 23, 2025 | seekingalpha.comStockNews.com Downgrades Innoviva (NASDAQ:INVA) to HoldStockNews.com lowered Innoviva from a "buy" rating to a "hold" rating in a research report on Saturday.February 22, 2025 | marketbeat.comHussman Strategic Advisors Inc. Buys 42,000 Shares of Innoviva, Inc. (NASDAQ:INVA)Hussman Strategic Advisors Inc. grew its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 33.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 168,000 shares of the biotechnology company's stockFebruary 21, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Short Interest UpdateInnoviva, Inc. (NASDAQ:INVA - Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 8,810,000 shares, a drop of 10.2% from the January 15th total of 9,810,000 shares. Based on an average daily volume of 680,800 shares, the days-to-cover ratio is currently 12.9 days. Approximately 14.2% of the company's stock are short sold.February 18, 2025 | marketbeat.comNewtyn Management, LLC Increases Stake in Theravance Biopharma IncFebruary 14, 2025 | gurufocus.comEntropy Technologies LP Acquires New Holdings in Innoviva, Inc. (NASDAQ:INVA)Entropy Technologies LP bought a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 14,298 shares of the biotechnology company's stock, valued at approximately $248,000. Other institutionFebruary 14, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Lowered to Hold Rating by StockNews.comStockNews.com cut shares of Innoviva from a "buy" rating to a "hold" rating in a research note on Thursday.February 13, 2025 | marketbeat.comInnoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 6, 2025 | finance.yahoo.comInnoviva (NASDAQ:INVA) Upgraded at StockNews.comStockNews.com upgraded Innoviva from a "hold" rating to a "buy" rating in a research report on Wednesday.February 6, 2025 | marketbeat.comPacer Advisors Inc. Has $50.87 Million Stake in Innoviva, Inc. (NASDAQ:INVA)Pacer Advisors Inc. grew its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 4.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,932,113 shares of the biotechnology company's stock after buJanuary 28, 2025 | marketbeat.comCantor Fitzgerald Weighs in on Innoviva FY2025 EarningsInnoviva, Inc. (NASDAQ:INVA - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Innoviva in a note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst L. Chen expects that the biotechnology company will post earnJanuary 22, 2025 | marketbeat.comJPMorgan Chase & Co. Has $11.17 Million Stake in Innoviva, Inc. (NASDAQ:INVA)JPMorgan Chase & Co. boosted its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 14.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 578,243 shares of the biotechnology company's sJanuary 13, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Downgraded to Hold Rating by StockNews.comStockNews.com lowered shares of Innoviva from a "buy" rating to a "hold" rating in a report on Tuesday.December 31, 2024 | marketbeat.comBarclays PLC Purchases 72,192 Shares of Innoviva, Inc. (NASDAQ:INVA)Barclays PLC boosted its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 254.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 100,594 shares of the biotechnology compaDecember 27, 2024 | marketbeat.comInnoviva's (NASDAQ:INVA) investors will be pleased with their 26% return over the last five yearsDecember 25, 2024 | finance.yahoo.comInnoviva, Inc. (NASDAQ:INVA) Shares Bought by Jane Street Group LLCJane Street Group LLC boosted its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 46.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 136,361 shares of the biotechnology company's stoDecember 22, 2024 | marketbeat.comWellington Management Group LLP Lowers Holdings in Innoviva, Inc. (NASDAQ:INVA)Wellington Management Group LLP reduced its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 60.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,166 shares of the biotechnology compDecember 21, 2024 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Short Interest Down 7.5% in NovemberInnoviva, Inc. (NASDAQ:INVA - Get Free Report) was the recipient of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 10,730,000 shares, a decrease of 7.5% from the November 15th total of 11,600,000 shares. Currently, 17.3% of the company's shares are sold short. Based on an average daily volume of 601,600 shares, the days-to-cover ratio is presently 17.8 days.December 16, 2024 | marketbeat.comInnoviva In Deal With Basilea Pharma To Buy U.S. Marketing Rights For ZevteraDecember 16, 2024 | markets.businessinsider.comInnoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)December 16, 2024 | finance.yahoo.comBasilea Collaborates With Innoviva Specialty Therapeutics For Commercialization Of Zevtera In The USDecember 16, 2024 | markets.businessinsider.comBasilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United StatesDecember 16, 2024 | globenewswire.comCharles Schwab Investment Management Inc. Reduces Stock Position in Innoviva, Inc. (NASDAQ:INVA)Charles Schwab Investment Management Inc. decreased its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 11.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 732,296 shares of the biotechnology companDecember 9, 2024 | marketbeat.comSystematic Financial Management LP Raises Holdings in Innoviva, Inc. (NASDAQ:INVA)Systematic Financial Management LP grew its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 4.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 1,979,073 shares of the biotechnology company's stock after buying an additional 89,633 sharDecember 5, 2024 | marketbeat.com Remove Ads Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address INVA Media Mentions By Week INVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INVA News Sentiment▼1.120.63▲Average Medical News Sentiment INVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INVA Articles This Week▼32▲INVA Articles Average Week Remove Ads Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amicus Therapeutics News Ligand Pharmaceuticals News Dynavax Technologies News BioCryst Pharmaceuticals News MannKind News Celldex Therapeutics News Novavax News OPKO Health News Geron News Myriad Genetics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INVA) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innoviva, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innoviva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INVA Stock Free INVA Stock Alerts